https://www.selleckchem.com/products/AZD0530.html
4 (5.4-8. vs. 2.0 (1.5-2.8) mcg/kg/min; p 0.001, respectively). No differences were observed in secondary clinical endpoints. Fixed-dose cisatracurium was associated with similar ventilatory and clinical outcomes compared to titrated strategy, yet it was associated with a 3-fold increase in dose administered. Fixed-dose cisatracurium was associated with similar ventilatory and clinical outcomes compared to titrated strategy, yet it was associated with a 3-fold increase in dose administered. To investigate the association between
Like
Comment
Share
